Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mammary Neoplasms, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01548677
What this trial is testing

Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer

Who this might be right for
Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastCirculating Tumor Cells
European Organisation for Research and Treatment of Cancer - EORTC 1,317
Very early researchNot Yet RecruitingNCT07671092
What this trial is testing

Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

Who this might be right for
Metastatic Urothelial CarcinomaBreast CancerTNBC - Triple-Negative Breast Cancer+2 more
RayzeBio, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06827236
What this trial is testing

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Who this might be right for
Locally Advanced Breast CancerUnresectable Breast CarcinomaMetastatic Breast Cancer
BioNTech SE 380
Not applicableStudy completedNCT06961331
What this trial is testing

Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.

Who this might be right for
Metastatic HER2+ Advanced Breast Cancer
Pfizer 86
Post-approval studies (Phase 4)Study completedNCT04009941
What this trial is testing

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerNeutropenia
Peking University 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT04553133
What this trial is testing

PF-07104091 as a Single Agent and in Combination Therapy

Who this might be right for
Small Cell Lung CancerOvarian CancerBreast Cancer
Pfizer 157
Not applicableStudy completedNCT06003114
What this trial is testing

Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs

Who this might be right for
Breast Cancer
Pfizer 472
Not applicableNot Yet RecruitingNCT06708221
What this trial is testing

A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy Methods

Who this might be right for
Cancer
University of Sydney 40
Not applicableNot Yet RecruitingNCT07758127
What this trial is testing

Updates and Insights on HER2 in Breast Cancer in Sohag Governorate

Who this might be right for
HER2 Status in Breast Cancer
Sohag University 100
Testing effectiveness (Phase 2)UnknownNCT04318223
What this trial is testing

Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast Cancer
Consorzio Oncotech 168
Early research (Phase 1)Study completedNCT03930680
What this trial is testing

Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane

Who this might be right for
Degradation of Top2b and Top2a in Human by DexrazoxaneTime Course and Degradation of Top2b in Human by DexrazoxaneEffects of Dexrazoxane on Healthy Human
University of Arkansas 25
Testing effectiveness (Phase 2)Study completedNCT00284180
What this trial is testing

Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsBreast Cancer
SCRI Development Innovations, LLC 32
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Early research (Phase 1)Looking for participantsNCT06784193
What this trial is testing

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Olema Pharmaceuticals, Inc. 180
Large-scale testing (Phase 3)Ended earlyNCT00968968
What this trial is testing

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Who this might be right for
Cancer
Novartis Pharmaceuticals 37
Early research (Phase 1)WithdrawnNCT01741597
What this trial is testing

Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasLiver Metastases+5 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT03519178
What this trial is testing

PF-06873600 in People With Cancer

Who this might be right for
HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer
Pfizer 155
Post-approval studies (Phase 4)Not Yet RecruitingNCT07630948
What this trial is testing

Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer

Who this might be right for
Breast CancerAdherence, Medication
Institute of Oncology Ljubljana 90
Not applicableStudy completedNCT00897468
What this trial is testing

Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 26
Early research (Phase 1)Study completedNCT03364348
What this trial is testing

4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaRecurrent Breast CarcinomaStage III Breast Cancer+4 more
George W. Sledge Jr. 18
Next Page